Rebecca Fitzgerald

A variety of new developments in the realms of screening and surveillance of Barrett's esophagus have occurred in recent years. This session will focus on the current evidence base for risk assessment algorithms to enhance screening uptake, new screening tools and obstacles to implementation…

A variety of new developments in the realms of screening and surveillance of Barrett's esophagus have occurred in recent years. This session will focus on the current evidence base for risk assessment algorithms to enhance screening uptake, new screening tools and obstacles to implementation…

Screening for Barrett’s esophagus (BE) could lead to earlier detection and improved survival of esophageal adenocarcinoma (EAC)…

Esophageal adenocarcinoma (EAC) is increasingly prevalent, with most cases detected in advanced stages and exhibiting less than a 20% 5-year overall survival rate. Since this cancer develops from Barrett's Esophagus (BE) through dysplastic stages, there is a clear opportunity for early diagnosis…

Endoscopic surveillance is recommended for Barrett’s esophagus (BE), but the effectiveness is questionable and varies according to expertise. Pan-oesophageal cell collection devices with biomarkers offer a less operator dependent alternative…